MARVEL ENTERPRISES INC
SC 13G, 1999-11-12
DOLLS & STUFFED TOYS
Previous: COMMUNITY BANK SHARES OF INDIANA INC, 10-Q, 1999-11-12
Next: MIRAVANT MEDICAL TECHNOLOGIES, 10-Q, 1999-11-12




                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13G

                    Under the Securities Exchange Act of 1934

                            Marvel Enterprises, Inc.

                                (Name of Issuer)


                          Common Stock, $.01 par value

                     8% Cumulative Convertible Exchangeable
                         Preferred Stock, par value $.01

                         (Title of Class of Securities)

                           Common Stock - 57383M 10 8
                          Preferred Stock - 57383M 20 7
                                 (CUSIP Number)


                                November 1, 1999

             (Date of Event Which Requires Filing of this Statement)

Check the  appropriate box to designate the rule pursuant to which this Schedule
is filed:

                 /   /            Rule 13d-1(b)
                 / x /            Rule 13d-1(c)
                 /   /            Rule 13d-1(d)

The  remainder  of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent   amendment   containing   information  which  would  alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).


<PAGE>



                                  SCHEDULE 13G


CUSIP No.
         Common Stock -    57383M 10 8
         Preferred Stock - 57383M 20 7

1        NAME OF REPORTING PERSON
                 MHR INSTITUTIONAL PARTNERS LP

         S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON


2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                      (a) /X/
                                                                      (b) / /
3        SEC USE ONLY                                                        //

4        CITIZENSHIP OR PLACE OF ORGANIZATION
                 DELAWARE


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

         5       SOLE VOTING POWER
                          COMMON STOCK:                     1,589,203/1/
                          PREFERRED STOCK:                  1,529,550

         6       SHARED VOTING POWER
                          0

         7       SOLE DISPOSITIVE POWER
                          COMMON STOCK:                     1,589,203/1/
                          PREFERRED STOCK:                  1,529,550


         8       SHARED DISPOSITIVE POWER
                          0

9        AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
                          COMMON STOCK:                     1,589,203/1/
                          PREFERRED STOCK:                  1,529,550


10       CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
         SHARES*
                 //

11       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
                          COMMON STOCK:                     4.53%
                          PREFERRED STOCK:                  8.69%


12       TYPE OF REPORTING PERSON*
                          PN


/1/ Includes  1,589,203 shares of Common Stock that the Reporting Person has the
right to  acquire  upon  conversion  of  1,529,550  shares  of the  Issuer's  8%
Convertible  Exchangeable  Preferred Stock (the  "Preferred  Stock") held by the
Reporting Person.


<PAGE>



                                  SCHEDULE 13G

CUSIP No.
         Common Stock -    57383M 10 8
         Preferred Stock - 57383M 20 7

1        NAME OF REPORTING PERSON
                 MHRM PARTNERS LP

         S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON


2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                      (a) /X/
                                                                      (b) / /
3        SEC USE ONLY


4        CITIZENSHIP OR PLACE OF ORGANIZATION
                 DELAWARE


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

         5       SOLE VOTING POWER
                          COMMON STOCK:                     168,831/2/
                          PREFERRED STOCK:                  162,494

         6       SHARED VOTING POWER
                          0

         7       SOLE DISPOSITIVE POWER
                          COMMON STOCK:                     168,831/2/
                          PREFERRED STOCK:                  162,494


         8       SHARED DISPOSITIVE POWER
                          0

9        AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
                          COMMON STOCK:                     168,831/2/
                          PREFERRED STOCK:                  162,494


10       CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
         SHARES*
                 //

11       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
                          COMMON STOCK:                     0.50%
                          PREFERRED STOCK:                  0.92%

12       TYPE OF REPORTING PERSON*
                          PN



/2/ Includes  168,831  shares of Common Stock that the Reporting  Person has the
right to acquire upon  conversion of 162,494  shares of Preferred  Stock held by
the Reporting Person.


<PAGE>



                                  SCHEDULE 13G

CUSIP No.
         Common Stock -    57383M 10 8
         Preferred Stock - 57383M 20 7

1        NAME OF REPORTING PERSON
                 MHR CAPITAL PARTNERS LP

         S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON


2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                      (a) /X/
                                                                      (b) / /
3        SEC USE ONLY

4        CITIZENSHIP OR PLACE OF ORGANIZATION
                 DELAWARE


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

         5       SOLE VOTING POWER
                          COMMON STOCK:                     317,127/3/
                          PREFERRED STOCK:                  227,234

         6       SHARED VOTING POWER
                          0

         7       SOLE DISPOSITIVE POWER
                          COMMON STOCK:                     317,127/3/
                          PREFERRED STOCK:                  227,234


         8       SHARED DISPOSITIVE POWER
                          0

9        AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
                          COMMON STOCK:                     317,127/3/
                          PREFERRED STOCK:                  227,234

10       CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
         SHARES*
                 //

11       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
                          COMMON STOCK:                     0.94%
                          PREFERRED STOCK:                  1.29%


12       TYPE OF REPORTING PERSON*
                          PN



/3/ Includes  236,096  shares of Common Stock that the Reporting  Person has the
right to acquire upon  conversion of 227,234  shares of Preferred  Stock held by
the Reporting Person.


<PAGE>



                                  SCHEDULE 13G

CUSIP No.
         Common Stock -    57383M 10 8
         Preferred Stock - 57383M 20 7

1        NAME OF REPORTING PERSON
                 MHR INSTITUTIONAL ADVISORS LLC

         S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON


2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                      (a) /X/
                                                                      (b) / /
3        SEC USE ONLY

4        CITIZENSHIP OR PLACE OF ORGANIZATION
                 DELAWARE


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

         5       SOLE VOTING POWER
                          0

         6       SHARED VOTING POWER
                          COMMON STOCK:       1,758,034/4/    (See Item 4)
                          PREFERRED STOCK:    1,692,044       (See Item 4)

         7       SOLE DISPOSITIVE POWER
                          0


         8       SHARED DISPOSITIVE POWER
                          COMMON STOCK:       1,758,034/4/    (See Item 4)
                          PREFERRED STOCK:    1,692,044       (See Item 4)

9        AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
                          COMMON STOCK:       1,758,034/4/    (See Item 4)
                          PREFERRED STOCK:    1,692,044       (See Item 4)


10       CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
         SHARES*
                 //

11       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
                          COMMON STOCK:                     4.98%
                          PREFERRED STOCK:                  9.62%

12       TYPE OF REPORTING PERSON*
                          OO



/4/ Includes 1,589,203 and 168,831 shares of Common Stock that MHR Institutional
Partners LP and MHRM Partners LP,  respectively,  have the right to acquire upon
conversion of the 1,529,550 and 162,494 shares of Preferred  Stock held by each,
respectively, which shares the Reporting Person may be deemed to be a beneficial
owner of by reason of its  position  as  general  partner  of each such  entity.
Pursuant to Rule 13d-4, the Reporting Person disclaims  beneficial  ownership of
such shares.


<PAGE>



                                  SCHEDULE 13G

CUSIP No.
         Common Stock -    57383M 10 8
         Preferred Stock - 57383M 20 7

1        NAME OF REPORTING PERSON
                 MHR ADVISORS LLC

         S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON


2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                      (a) /X/
                                                                      (b) / /
3        SEC USE ONLY

4        CITIZENSHIP OR PLACE OF ORGANIZATION
                 DELAWARE


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

         5       SOLE VOTING POWER
                          0

         6       SHARED VOTING POWER
                          COMMON STOCK:       317,127/5/      (See Item 4)
                          PREFERRED STOCK:    227,234         (See Item 4)

         7       SOLE DISPOSITIVE POWER
                          0


         8       SHARED DISPOSITIVE POWER
                          COMMON STOCK:       317,127/5/      (See Item 4)
                          PREFERRED STOCK:    227,234         (See Item 4)

9        AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
                          COMMON STOCK:       317,127/5/      (See Item 4)
                          PREFERRED STOCK:    227,234         (See Item 4)


10       CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
         SHARES*
                 //

11       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
                          COMMON STOCK:       0.94%
                          PREFERRED STOCK:    1.29%

12       TYPE OF REPORTING PERSON*
                          OO



/5/ Includes 236,096 shares of Common Stock that MHR Capital Partners LP has the
right to acquire upon  conversion of the 227,234 shares of Preferred  Stock held
by it which the  Reporting  Person may be deemed to be a beneficial  owner of by
reason of its position as general  partner of MHR Capital  Partners LP. Pursuant
to Rule 13d-4,  the  Reporting  Person  disclaims  beneficial  ownership of such
shares.




<PAGE>



                                  SCHEDULE 13G

CUSIP No.
         Common Stock -    57383M 10 8
         Preferred Stock - 57383M 20 7

1        NAME OF REPORTING PERSON
                 Mark H. Rachesky, M.D.

         S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON


2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                      (a) /X/
                                                                      (b) / /
3        SEC USE ONLY

4        CITIZENSHIP OR PLACE OF ORGANIZATION
                 USA


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

         5       SOLE VOTING POWER
                          0

         6       SHARED VOTING POWER
                          COMMON STOCK:       2,075,161/7/    (See Item 4)
                          PREFERRED STOCK:    1,919,278       (See Item 4)

         7       SOLE DISPOSITIVE POWER
                          0


         8       SHARED DISPOSITIVE POWER
                          COMMON STOCK:       2,075,161/7/    (See Item 4)
                          PREFERRED STOCK:    1,919,278       (See Item 4)

9        AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
                          COMMON STOCK:       2,075,161/2/    (See Item 4)
                          PREFERRED STOCK:    1,919,278/2/    (See Item 4)


10       CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
         SHARES*
                 //

11       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
                          COMMON STOCK:       5.84%
                          PREFERRED STOCK:    10.91%

12       TYPE OF REPORTING PERSON*
                          OO



/6/  Includes  1,589,203,  168,831 and 236,096  shares of Common  Stock that MHR
Institutional  Partners  LP,  MHRM  Partners  LP, and MHR Capital  Partners  LP,
respectively,  have the  right to  acquire  upon  conversion  of the  1,529,550,
162,494 and 227,234 shares of Preferred Stock held by each, respectively,  which
shares the Reporting  Person may be deemed to be a beneficial owner of by reason
of his  position  as  managing  member of each of the  general  partners of such
entities.  Pursuant to Rule 13d-4,  the Reporting  Person  disclaims  beneficial
ownership of such shares.



<PAGE>



                                  SCHEDULE 13G


         This  Statement on Schedule 13G relates to shares of common stock,  par
value $.01 per share (the  "Common  Stock")  and the 8%  Cumulative  Convertible
Exchangeable  Preferred Stock, par value $.01 per share (the "Preferred Stock"),
of Marvel Enterprises, Inc., a Delaware corporation (the "Issuer").

ITEM 1

(a)      Name of Issuer: Marvel Enterprises, Inc. (f/k/a Toy Biz, Inc.)

(b)      Address of Issuers Principal Executive Offices:
                 387 Park Avenue South
                 New York, New York 10016


ITEM 2

(a) - (c)        The persons filing this statement (each, a "Reporting
                 Person" and collectively, the "Reporting Group") are: (i)
                 MHR Institutional Partners LP, a Delaware limited
                 partnership ("Institutional Partners"); (ii) MHRM Partners
                 LP, a Delaware limited partnership ("MHRM"); (iii) MHR
                 Capital Partners LP, a Delaware limited partnership
                 ("Capital Partners"); (iv) MHR Institutional Advisors LLC,
                 a Delaware limited liability company ("Institutional
                 Advisors") and the general partner of Institutional
                 Partners and MHRM; (v) MHR Advisors LLC, a Delaware
                 limited liability company ("Advisors") and the general
                 partner of Capital Partners; and (vi) Mark H. Rachesky,
                 M.D., the managing member of  Institutional Advisors and
                 Advisors.  Each Reporting Person has an office at 40 West
                 57th Street, 33rd Floor, New York, New York, 10019.

(d)              Title of Class of Securities:  Common Stock, par value
                 $.01 per share

                 Title of Class of Securities:  8% Cumulative Convertible
                 Exchangeable Preferred Stock, par value $.01 per share

(e)              CUSIP Number for Common Stock:    57383M 10 8
                 CUSIP Number for Preferred Stock: 57383M 20 7


ITEM             3 If this  statement  is filed  pursuant to Rule  13d-1(b),  or
                 13d-2(b), check whether the person filing is a:

         (a)     /  /     Broker or Dealer registered under Section 15 of the
                          Act
         (b)     /  /     Bank as defined in Section 3(a)(6) of the Act
         (c)     /  /     Insurance company as defined in Section 3(a)(19) of
                          the Act
         (d)     /  /     Investment Company registered under Section 8 of the
                          Investment Company Act
         (e)     /  /     Investment Adviser registered under Section 203 of
                          the Investment Advisers Act of 1940
         (f)     /  /     Employee  Benefit  Plan,  Pension  Fund  which is
                          subject to the  provisions of the Employee  Retirement
                          Income  Security  Act of 1974 or Endowment  Fund;  see
                          Section
                          240.13d-1(b)(1)(ii)(F)
         (g)     /  /     Parent Holding Company, in accordance with Section
                          240.13d-1(b)(ii)(G)
         (h)     /  /     Group, in accordance with Section
                          240.13d-1(b)(1)(ii)(H)



<PAGE>



ITEM 4           Ownership

         Institutional  Partners  currently owns  1,529,550  shares of Preferred
Stock which  represents  8.69% of the Preferred  Stock  outstanding  (based upon
17,592,257  shares of Preferred Stock,  which number was calculated based on the
52,184,538  shares of Common Stock stated to be  outstanding as of June 30, 1999
by the Issuer in the Issuer's Form 10-Q for the quarter ended June 30, 1999 (the
"10-Q"), assuming the conversion of all Preferred Stock) and which Institutional
Partners has the right to convert into 1,589,203  shares of Common Stock,  which
represents  4.53% of the Common  Stock  outstanding  (based upon the  33,532,159
shares  of Common  Stock  stated to be  outstanding  as of June 30,  1999 by the
Issuer in the 10-Q).  Capital  Partners owns 227,234  shares of Preferred  Stock
which represents  1.29% of the Preferred Stock  outstanding and 81,031 shares of
Common Stock.  Capital Partners has the right to convert its shares of Preferred
Stock into  236,096  shares of Common  Stock which  together  with the shares of
Common  Stock  held by Capital  Partners  represents  0.94% of the Common  Stock
outstanding.  MHRM owns 162,494 shares of Preferred Stock which represents 0.92%
of the Preferred Stock  outstanding and which MHRM has the right to convert into
168,831  shares of Common  Stock,  which  represents  0.50% of the Common  Stock
outstanding.  Institutional  Advisors may be deemed to be a beneficial  owner of
1,529,550  shares of Preferred  Stock and 162,494 shares of Preferred Stock held
by Institutional Partners and MHRM,  respectively,  by reason of its position as
general  partner of each of  Institutional  Partners and MHRM.  Pursuant to Rule
13d-4  promulgated  under  the  Act,   Institutional   Advisors  disclaims  such
beneficial  ownership.  Advisors may be deemed to be a  beneficial  owner of the
81,031  shares of Common  Stock and 227,234  shares of  Preferred  Stock held by
Capital  Partners  by reason of its  position  as  general  partner  of  Capital
Partners.  Pursuant to Rule 13d-4 promulgated under the Act, Advisors  disclaims
such  beneficial  ownership.  Mark  H.  Rachesky,  M.D.  may be  deemed  to be a
beneficial   owner  of  (i)  the  1,692,044  shares  of  Preferred  Stock  which
Institutional  Advisors may be deemed to be a beneficial  owner of, and (ii) the
81,031  shares of Common  Stock and  227,234  shares of  Preferred  Stock  which
Advisors may be deemed to be a beneficial owner of, by reason of his position as
the  managing  member of  Institutional  Advisors  and  Advisors,  respectively.
Pursuant  to Rule 13d-4,  Dr.  Rachesky  disclaims  such  beneficial  ownership.
Pursuant to Rule 13d-3  promulgated  under the Act, the  Reporting  Group may be
deemed to be a beneficial owner of an aggregate of 1,919,278 shares of Preferred
Stock  representing  10.91% of the Preferred Stock outstanding and 81,031 shares
of Common Stock which,  together with the 1,994,130 shares of Common Stock which
the  Reporting  Group has the right to acquire upon  conversion of the shares of
Preferred  Stock which the members of the Reporting  Group may be deemed to be a
beneficial owner of, represents 5.84% of the Common Stock outstanding.


         Each of Institutional  Partners, MHRM and Capital Partners has the sole
power to vote and dispose of all shares of Common  Stock,  if any, and Preferred
Stock  that  it  owns.   Institutional   Advisors  is  the  general  partner  of
Institutional Partners and MHRM. Therefore, Institutional Advisors may be deemed
to be a beneficial  owner of the 1,529,550 and 162,494 shares of Preferred Stock
owned by Institutional  Partners and MHRM,  respectively,  with the shared power
with Institutional Partners and MHRM,  respectively,  to vote or direct the vote
and the shared  power with  Institutional  Partners and MHRM,  respectively,  to
dispose or direct the  disposition  of,  such  shares.  Advisors  is the general
partner of Capital Partners. Therefore Advisors may be deemed to be a beneficial
owner of the 81,031 shares of Common Stock and 227,234 shares of Preferred Stock
owned by Capital  Advisors,  with the shared power with Capital Partners to vote
or direct the vote and the  shared  power with  Capital  Partners  to dispose or
direct the disposition,  of such shares.  Dr. Rachesky is the managing member of
Institutional


<PAGE>



Advisors and Advisors.  Therefore, Dr. Rachesky may be deemed to be a beneficial
owner  of the (i)  1,692,044  shares  of  Preferred  Stock  which  Institutional
Partners  may be deemed to be a beneficial  owner of, and (ii) 81,031  shares of
Common Stock and 227,234 shares of Preferred  Stock which Advisors may be deemed
to be a beneficial  owner of, with the shared  power with each of  Institutional
Partners,  MHRM and Capital Partners,  respectively,  to vote or direct the vote
and the  shared  power with each of  Institutional  Partners,  MHRM and  Capital
Partners, respectively, to dispose or direct the disposition of, such shares.

         The filing of this  statement on Schedule 13G shall not be construed as
an  admission  that any member of the  Reporting  Group is, for the  purposes of
Sections 13(d) or 13(g) of the Act, the beneficial owner of any of the shares of
Preferred  Stock or  Common  Stock  owned by any other  member of the  Reporting
Group.  Pursuant to Rule 13d-4,each  member of the Reporting Group disclaims all
such beneficial ownership.




ITEM 5           Ownership of Five Percent or Less of a Class


                                 NOT APPLICABLE


ITEM 6           Ownership of More than Five Percent on Behalf of Another
                 Person

                                 NOT APPLICABLE


ITEM 7           Identification and Classification of the Subsidiary Which
                 Acquired the Security Being Reported on by the Parent
                 Holding Company

                                 NOT APPLICABLE


ITEM 8           Identification and Classification of Members of the Group

                 See Item 2

ITEM 9           Notice of Dissolution of Group

                                 NOT APPLICABLE


ITEM 10          Certification

         By  signing  below I  certify  that,  to the best of my  knowledge  and
belief,  the  securities  referred  to above were  acquired  and are held in the
ordinary  course  of  business  and were not  acquired  and are not held for the
purpose of or with the effect of  changing  or  influencing  the  control of the
Issuer of the  securities  and were not acquired and are not held in  connection
with or as a participant in any transaction having that purpose or effect.


<PAGE>



Exhibits
- --------

Exhibit 1                 Joint filing Agreement dated November 10, 1999_ by
                          and among MHR Institutional Partners LP, MHRM
                          Partners LP, MHR Capital Partners LP, MHR
                          Institutional Advisors LLC, MHR Advisors LLC and
                          Mark H. Rachesky, M.D.



<PAGE>


                                   SIGNATURES


                 After  reasonable  inquiry and to the best of the knowledge and
belief of each of the  undersigned,  each of the undersigned  certifies that the
information  set forth in this  statement on Schedule 13G is true,  complete and
correct.

Dated:   November 10, 1999

                                      MHR INSTITUTIONAL PARTNERS LP

                                      By: MHR Institutional Advisors LLC, its
                                              General Partner


                                      By: /s/ MARK H. RACHESKY
                                         ---------------------------------
                                              MARK H. RACHESKY, M.D.
                                              Managing Member


                                      MHRM PARTNERS LP

                                      By: MHR Institutional Advisors LLC, its
                                              General Partner


                                      By: /s/ MARK H. RACHESKY
                                         ---------------------------------
                                              MARK H. RACHESKY, M.D.
                                              Managing Member


                                      MHR CAPITAL PARTNERS LP

                                      By: MHR Advisors LLC, its General Partner


                                      By: /s/ MARK H. RACHESKY
                                         ---------------------------------
                                              MARK H. RACHESKY, M.D.
                                              Managing Member

                                      MHR INSTITUTIONAL ADVISORS LLC



                                      By:  /s/ MARK H. RACHESKY
                                         ----------------------------
                                              MARK H. RACHESKY, M.D.
                                              Manager Member


                                      MHR ADVISORS LLC


                                      By:  /s/ MARK H. RACHESKY
                                         ----------------------------
                                              MARK H. RACHESKY, M.D.
                                              Manager Member

                                              /s/ MARK H. RACHESKY
                                          -----------------------------
                                              MARK H. RACHESKY, M.D.










                             JOINT FILING AGREEMENT


                 In accordance with Rule 13d-1(k) under the Securities  Exchange
Act of 1934,  as amended,  the persons  named below agree to the joint filing on
behalf of each of them of a statement  on  Schedule  13G  (including  amendments
thereto)  with  respect  to the  Common  Stock,  par value $.01 per share and 8%
Cumulative Convertible Exchangeable Preferred Stock, $.01 par value per share of
Marvel  Enterprises,  Inc. and further agree that this Joint Filing Agreement be
included as an Exhibit to such joint filings.


                 The  undersigned  further  agree  that  each  party  hereto  is
responsible  for  timely  filing  of  such  statement  on  Schedule  13G and any
amendments  thereto,  and for the accuracy and  completeness  of the information
concerning such party contained  therein;  provided,  however,  that no party is
responsible for the accuracy and completeness of the information  concerning any
other  party,  unless  such  party  knows or has  reason  to  believe  that such
information is inaccurate.

                 IN  WITNESS   WHEREOF,   the  undersigned  have  executed  this
Agreement as of November 10, 1999.


                                   MHR INSTITUTIONAL PARTNERS LP

                                   By:     MHR Institutional Advisors LLC, its
                                           General Partner


                                   By: /s/ MARK H. RACHESKY
                                     ---------------------------------
                                       MARK H. RACHESKY, M.D.
                                       Managing Member


                                   MHRM PARTNERS LP

                                   By:     MHR Institutional Advisors LLC, its
                                           General Partner


                                   By: /s/ MARK H. RACHESKY
                                     ---------------------------------
                                        MARK H. RACHESKY, M.D.
                                        Managing Member







<PAGE>


                                   MHR CAPITAL PARTNERS LP

                                   By: MHR Advisors LLC, its General Partner


                                   By: /s/ MARK H. RACHESKY
                                     ---------------------------------
                                        MARK H. RACHESKY, M.D.
                                        Managing Member


                                   MHR INSTITUTIONAL ADVISORS LLC



                                   By: /s/ MARK H. RACHESKY
                                     ----------------------------
                                        MARK H. RACHESKY, M.D.
                                        Manager Member


                                   MHR ADVISORS LLC


                                   By: /s/ MARK H. RACHESKY
                                     ----------------------------
                                        MARK H. RACHESKY, M.D.
                                        Manager Member


                                       /s/ MARK H. RACHESKY
                                    -----------------------------
                                        MARK H. RACHESKY, M.D.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission